4
Changes in Ownership
DiaMedica Therapeutics Inc. Filed Acc 0001643127-25-000006
Options or other derivatives
- Chief Marketing Officer acquired 450,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Krop Julie Chief Marketing Officer | 2025-08-11 | Grant or award · Stock Option (right to buy) | +450,000 | 450,000 | D | ||
Loading xslF345X05/form4-11032025_091158.xml…